Clinical trial
Effects of Probiotic Treatment on Body Composition and Insulin Resistance in Patients With Obesity Grade II and III and Its Association With Changes in Intestinal Microbiota
NCT04086173 is registered in ClinicalTrials.gov with Hospital General de México Dr. Eduardo Liceaga as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Probiotic Treatment on Body Composition and Insulin Resistance in Patients With Obesity Grade II and III and Its Association With Changes in Intestinal Microbiota
- Lead sponsor
- Hospital General de México Dr. Eduardo Liceaga
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 1, 2018
- Completion date
- July 31, 2020
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
insulin resistance, microbial colonization, obesity